Skip to content
HomeLatest newsJohnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
JNJ-Earns-Spot-on-Fortunes-2021-Change-the-World-List-lede-B.jpg

Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.

The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.

This week Fortune included Johnson & Johnson on its 2021 Change the World list, which spotlights companies across the globe that have leveraged their core business strategies to drive positive social impact.

While the vaccine makers on last year’s list were recognized for their unprecedented collaboration on fighting the coronavirus, this year’s list highlights those that are helping expand access to COVID-19 vaccines around the world. Johnson & Johnson is honored to be included for its efforts to make available its Janssen COVID-19 vaccine, for which it received Emergency Use Authorization from the U.S. Food and Drug Administration in February.

To compile the prestigious list, Fortune evaluated companies on the impact they’ve made in addressing one or more of society’s problems, the business results of those actions and the level of innovation involved. Also taken into consideration: how essential the company’s initiative was to its overall business strategy.

A commitment to social responsibility and innovation

For more than a century, Johnson & Johnson has relied on a core set of values to guide every aspect of the way it does business.

When COVID-19 hit, the company was able to respond to the once-in-a-lifetime global health challenge by harnessing its capabilities, scientific expertise, global partnerships and experience in helping fight pandemics for over a century—and its 130,000-plus employees around the world mobilized with urgency to address the critical needs of families, communities and healthcare providers.

That sort of innovation and a commitment to social responsibility provide the foundation for Our Credo, the company mission statement that compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.

This isn’t the first time Fortune has recognized Johnson & Johnson. Earlier this month, Jennifer Taubert, the company’s Executive Vice President and Worldwide Chairman, Pharmaceuticals, was named to Fortune’s 2021 list of the Most Powerful Women in Business for the sixth consecutive year. In June, the company landed the #4 spot on Fortune’s Return on Leadership List, a ranking of the top 100 companies on the Fortune 500 list. And early this year, the brand included Johnson & Johnson among the World’s Most Admired Companies, placing it at #1 in the Pharmaceutical category worldwide for the eighth consecutive year.

Johnson & Johnson is proud to be recognized again.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.